Orange Book product · Generic (ANDA)
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
At a glance
Dec 01, 2015
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 01, 2015
10 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DEXAMETHASONE SODIUM PHOSPHATE
Strength
EQ 4MG PHOSPHATE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 206781
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DEXAMETHASONE SODIUM PHOSPHATE
- —DEXACORTBrand (NDA)
NDA 013413 · UCB INC
- —DEXACORTBrand (NDA)
NDA 014242 · UCB INC
- —DECADRONBrand (NDA)
NDA 011983 · MERCK
- —DECADRONBrand (NDA)
NDA 012071 · MERCK
- —HEXADROLBrand (NDA)
NDA 014694 · ASPEN GLOBAL INC
- —DECADRONBrand (NDA)
NDA 011977 · MERCK
- —DECADRONBrand (NDA)
NDA 011984 · MERCK
- 2024DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 217797 · MICRO LABS
- 2023DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 211451 · HIKMA
- 2023DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 214890 · GENEYORK PHARMS
- 2021DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 215654 · GLAND
- 2020DEXAMETHASONE SODIUM PHOSPHATEGeneric (ANDA)
ANDA 210966 · EUGIA PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
